0001387131-13-003788.txt : 20131011 0001387131-13-003788.hdr.sgml : 20131011 20131011143008 ACCESSION NUMBER: 0001387131-13-003788 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131011 DATE AS OF CHANGE: 20131011 EFFECTIVENESS DATE: 20131011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ohr Pharmaceutical Inc CENTRAL INDEX KEY: 0001173281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133709558 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-204449 FILM NUMBER: 131147746 BUSINESS ADDRESS: STREET 1: 1245 BRICKYARD RD STREET 2: #590 CITY: SALT LAKE CITY, STATE: UT ZIP: 84106 BUSINESS PHONE: 347-753-4389 MAIL ADDRESS: STREET 1: 1245 BRICKYARD RD STREET 2: #590 CITY: SALT LAKE CITY, STATE: UT ZIP: 84106 FORMER COMPANY: FORMER CONFORMED NAME: BBM HOLDINGS, INC. DATE OF NAME CHANGE: 20070402 FORMER COMPANY: FORMER CONFORMED NAME: PRIME RESOURCE INC DATE OF NAME CHANGE: 20020513 D 1 primary_doc.xml X0707 D LIVE 0001173281 Ohr Pharmaceutical Inc 489 FIFTH AVENUE NEW YORK, NY NEW YORK 10017 212-682-8452 DELAWARE None BBM HOLDINGS, INC. PRIME RESOURCE INC Corporation true Ira Greenstein c/o Ohr Pharmaceutical, Inc. 489 Fifth Avenue, 28th Floor New York NY NEW YORK 10017 Director Irach Taraporewala c/o Ohr Pharmaceutical, Inc. 489 Fifth Avenue, 28th Floor New York NY NEW YORK 10017 Executive Officer Director Orin Hirschman c/o Ohr Pharmaceutical, Inc. 489 Fifth Avenue, 28th Floor New York NY NEW YORK 10017 Director Thomas Riedhammer c/o Ohr Pharmaceutical, Inc. 489 Fifth Avenue, 28th Floor New York NY NEW YORK 10017 Director June Almenoff c/o Ohr Pharmaceutical, Inc. 489 Fifth Avenue, 28th Floor New York NY NEW YORK 10017 Director Sam Backenroth c/o Ohr Pharmaceutical, Inc. 489 Fifth Avenue, 28th Floor New York NY NEW YORK 10017 Executive Officer Biotechnology No Revenues 06b false 2013-10-02 false true true false 0 376915 376915 0 false 3 0 0 0 false Ohr Pharmaceutical Inc /s/ Sam Backenroth Sam Backenroth CFO & VP of Bus. Development 2013-10-11